XNAS
ALGN
Market cap10bUSD
Oct 21, Last price
151.43USD
1D
1.00%
1Q
-12.74%
Jan 2017
56.55%
IPO
733.31%
Name
Align Technology Inc
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Align Technology, Inc., a prominent medical device company, is dedicated to developing, producing, and commercializing innovative solutions for dental professionals. Its core offerings include the well-known Invisalign clear aligner system and the iTero line of intraoral scanners, complemented by associated services. The company caters to orthodontists, general dentists, and practitioners specializing in restorative and aesthetic dentistry. Its operations are primarily organized into two divisions: The Clear Aligner segment encompasses a comprehensive range of Invisalign products. This includes full treatment solutions like Invisalign comprehensive, tailored for adolescent patients and incorporating advanced features such as mandibular advancement, compliance indicators, and compensation for tooth eruption. It also offers specialized packages for younger children (typically ages seven to ten) with mixed dentition, known as Invisalign First Phase I and Invisalign First Comprehensive Phase 2. Beyond these extensive treatments, the segment provides less comprehensive options, including Invisalign moderate, lite, express packages, and Invisalign Go. Additionally, it supplies non-case related items such as retention devices, charges for Invisalign training, and sells supplementary products like cleaning materials and adjusting instruments utilized by dental professionals during treatment. The Scanners and Services segment focuses on the iTero scanner, a unified hardware platform equipped with various software functionalities for both restorative and orthodontic procedures. Its software for restorative dentistry serves general practitioners, prosthodontists, periodontists, and oral surgeons, while the orthodontic software aids practitioners in digital record keeping, diagnosis, and the creation of printed models and retainers. This segment further extends its offerings with computer-aided design and manufacturing (CAD/CAM) services, essential accessories like disposable wand sleeves, iTero models and dies, and supports third-party scanners and digital scans. Noteworthy innovations include the Invisalign Outcome Simulator, a chairside and cloud-based application for the iTero scanner, the Invisalign Progress Assessment Tool, and TimeLapse technology, which enables clinicians to compare a patient's historical 3D scans with current data. Align Technology distributes its products across global markets, including significant presence in the United States, Switzerland, and China. Established in 1997, the company maintains its corporate headquarters in Tempe, Arizona.
Related entities
Branches
ALIGNTECH DE MEXICO S DE RL DE CV
Key people
Charles Larkin
Independent Chairman of the Board · since 2006
Joseph Hogan
President, Chief Executive Officer, Director · since 2015
John Morici
Chief Financial Officer, Executive Vice President - Global Finance · since 2022
Julie Coletti
Executive Vice President, Chief Legal and Regulatory Officer · since 2022
Director · since 2025
Kevin Conroy
Independent Director · since 2023
Kevin Dallas
Independent Director · since 2018
Independent Director · since 1997
Independent Director · since 2006
Anne Myong
Independent Director · since 2019
Mojdeh Poul
Independent Director · since 2023
Andrea Saia
Independent Director · since 2013
Independent Director · since 2017
Headquarters & legal address
251 LITTLE FALLS DRIVE
WILMINGTON, DE 19808
US
WILMINGTON, DE 19808
US
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||